Health Condition 1: N970- Female infertility associated withanovulation
Conditions
Interventions
None listed
Sponsors
Dr PRABHA YADAV
Eligibility
Inclusion criteria
Inclusion criteria: Oligo ovulation or Anovulation ,irregular menstrual cycle ,confirmed tubal patency (i.e no tubal factor infertility ),partner with normal semen analysis ,no significant structural abnormalities (i.e large fibroids ,adhesions )
Exclusion criteria
Exclusion criteria: patients having pelvic inflammatory disorders ,patients having anatomical or uterine pathology ,fibroids ,adenomyosis ,cervical stenosis ,endometriosis ,Endometrial polyp ,patients suffering from diabetes ,HTN .patient taking hormonal therapy ,congential anamolies of reproductive system ,tubal blockage or endometriosis ,uterine abnormalities impacting implantation .uncontrolled thyroid and prolactin disorders .severe male factor infertility .female with very low AMH level
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ovulation rate improved and it is assessed by follicular rupture on transvaginal sonographyTimepoint: 3 months the trial drug is given for 3 months with anupana and follow up will be done after every menstrual cycle | — |
Secondary
| Measure | Time frame |
|---|---|
| improvement in follicular size & endometrial thickness ,improvement in menstrual bleeding & duration between 2 cyclesTimepoint: 3 months | — |
Countries
India
Contacts
Public ContactDr PRABHA YADAV
Jeevan Jyoti Ayurvedic Medical college and hospital Aligarh
Outcome results
None listed